Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 1
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
[SGLT 2 inhibitors in Type 1 diabetes].
Stougaard EB, Amadid H, Søndergaard E, Jørgensen ME, Persson F, Rossing P. Stougaard EB, et al. Ugeskr Laeger. 2020 Aug 24;182(35):V05200351. Ugeskr Laeger. 2020. PMID: 32829747 Free article. Review. Danish.
Sotagliflozin, a dual sodium-glucose co-transporter-1 and sodium-glucose co-transporter-2 inhibitor, reduces the risk of cardiovascular and kidney disease, as assessed by the Steno T1 Risk Engine in adults with type 1 diabetes.
Stougaard EB, Rossing P, Vistisen D, Banks P, Girard M, Davies MJ, Persson F. Stougaard EB, et al. Diabetes Obes Metab. 2023 Jul;25(7):1874-1882. doi: 10.1111/dom.15047. Epub 2023 Mar 20. Diabetes Obes Metab. 2023. PMID: 36872068 Clinical Trial.
Endothelial glycocalyx and cardio-renal risk factors in type 1 diabetes.
Stougaard EB, Winther SA, Amadid H, Frimodt-Møller M, Persson F, Hansen TW, Rossing P. Stougaard EB, et al. PLoS One. 2021 Jul 30;16(7):e0254859. doi: 10.1371/journal.pone.0254859. eCollection 2021. PLoS One. 2021. PMID: 34329330 Free PMC article. Clinical Trial.
Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis.
Stougaard EB, Kristensen PL, Kielgast U, Andersen HU, Hamid Y, Gæde PH, Søndergaard E, Dørflinger GH, Fjeldborg KK, Hansen KW, Thomsen HH, Al-Imar TMJ, Røder M, Sridhar VS, Cherney D, Rossing P, Persson F. Stougaard EB, et al. Diab Vasc Dis Res. 2022 Sep-Oct;19(5):14791641221130043. doi: 10.1177/14791641221130043. Diab Vasc Dis Res. 2022. PMID: 36262089 Free PMC article.
Effects of Butyrate Supplementation on Inflammation and Kidney Parameters in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial.
Tougaard NH, Frimodt-Møller M, Salmenkari H, Stougaard EB, Zawadzki AD, Mattila IM, Hansen TW, Legido-Quigley C, Hörkkö S, Forsblom C, Groop PH, Lehto M, Rossing P. Tougaard NH, et al. Among authors: stougaard eb. J Clin Med. 2022 Jun 21;11(13):3573. doi: 10.3390/jcm11133573. J Clin Med. 2022. PMID: 35806857 Free PMC article.